Patent ID: 11918671
Assignee: HENKEL AG & CO. KGAA
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 12:
13. The method of claim 2, wherein the agent (Al) comprises at least one developer component selected from the group of p-phenylenediamine, p-toluylenediamine, 2-(beta-hydroxyethyl)-p-phenylenediamine, 2-methoxymethyl-p-phenylenediamine, 2-(alpha, beta-dihydroxyethyl)-p-phenylenediamine, N,N-bis-(beta-hydroxyethyl)-p-phenylenediamine, N-(4-amino-3-methylphenyl)-N[3-(1H-imidazol-1-yl)propyl] amine, N,N′-bis-(beta-hydroxyethyl)-N,N′-bis-(4-aminophenyl)-1,3-diamino-propan-2-ol, bis-(2-hydroxy-5-aminophenyl)-methane, 1,3-bis-(2,5-diaminophenoxy)-propan-2-ol, N,N′-bis-(4-aminophenyl)-1,4-diazacycloheptane, 1, 10-bis-(2,5-diaminophenyl)-1,4,7,10-tetraoxadecane, p-aminophenol, 4-amino-3-methylphenol, 4-amino-2-aminomethylphenol, 4-amino-2-(alpha, beta-dihydroxyethyl)-phenol and 4-amino-2-(diethylaminomethyl)-phenol, 4,5-diamino-1-(beta-hydroxyethyl)-pyrazole, 2,4,5,6-tetraaminopyrimidine, 4-hydroxy-2,5,6-triaminopyrimidine, 2-hydroxy-4,5,6-triaminopyrimidine, physiologically tolerated salts thereof, and combinations thereof.